IOSP - Innospec Inc.
Innospec Inc. (NASDAQ: IOSP - Get Free Report) shares passed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $84.21 and traded as high as $99.22. Innospec shares last traded at $98.55, with a volume of 233,649 shares traded. Wall Street Analysts Forecast Growth IOSP has been the
ENGLEWOOD, Colo., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release third quarter 2026 earnings results on Tuesday, November 3, 2026 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, November 4, 2026, at 9:00 a.m. ET.
5N Plus (OTCMKTS:FPLSF - Get Free Report) and Innospec (NASDAQ: IOSP - Get Free Report) are both materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, institutional ownership and valuation. Analyst Ratings This is a breakdown of recent recommendations
Innospec Inc. (NASDAQ: IOSP - Get Free Report)'s stock price hit a new 52-week high during mid-day trading on Wednesday. The stock traded as high as $97.20 and last traded at $95.8390, with a volume of 5030 shares traded. The stock had previously closed at $96.08. Analyst Ratings Changes A number of research firms have commented
Squarepoint Ops LLC cut its stake in Innospec Inc. (NASDAQ: IOSP) by 37.0% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,379 shares of the specialty chemicals company's stock after selling 6,107 shares during the quarter. Squarepoint Ops LLC's
Innospec (IOSP) reported earnings 30 days ago. What's next for the stock?
The Zacks Chemicals Diversified is expected to benefit from healthy demand across major end-use markets and the end of destocking activities. APD, DD, AVNT and IOSP are set to gain from strategic actions and demand recovery.
With the oilfield segment leading topline growth, even more growth should be expected as the adoption of DRA expands and the firm re-enters the Mexico market. In Q2 of 2026, revenue grew 12%, beating estimates by $34.17 million. The firm is now in a better financial position to command a higher sales multiple. The Performance chemical segment still experiences volume declines, raising concerns about the firm over investing by adding 10% capacity in a weak market.
Innospec's Q2 earnings beat estimates as all three businesses delivered revenue growth, while a debt-free balance sheet supports further investment.
Here is how Innospec (IOSP) and Ingevity (NGVT) have performed compared to their sector so far this year.
Shares of Innospec Inc. (NASDAQ: IOSP - Get Free Report) hit a new 52-week high during trading on Wednesday following a stronger than expected earnings report. The stock traded as high as $93.01 and last traded at $91.64, with a volume of 232644 shares changing hands. The stock had previously closed at $86.70. The specialty chemicals
Arrowstreet Capital Limited Partnership lifted its holdings in Innospec Inc. (NASDAQ: IOSP) by 196.5% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 18,497 shares of the specialty chemicals company's stock after purchasing an additional 12,259 shares during the period. Arrowstreet Capital Limited Partnership owned
Innospec Inc. (IOSP) Q2 2026 Earnings Call Transcript
Innospec NASDAQ: IOSP reported higher second-quarter revenue and net income as all three operating segments posted double-digit sales growth and operating-income gains, while the company continued repair and optimization work at its North Carolina Performance Chemicals facilities.
Innospec (IOSP) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.26 per share a year ago.
Strong contributions from all businesses with revenues up 12 percent and operating income up 16 percent
Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investors with an interest in Chemical - Diversified stocks have likely encountered both Innospec (IOSP) and Air Products and Chemicals (APD). But which of these two stocks is more attractive to value investors?
Investors looking for stocks in the Chemical - Diversified sector might want to consider either Innospec (IOSP) or Air Liquide (AIQUY). But which of these two stocks presents investors with the better value opportunity right now?
ENGLEWOOD, Colo., July 06, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release second quarter 2026 earnings results on Tuesday, August 4, 2026 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, August 5, 2026, at 10:00 a.m. ET.